Preferred Label : peginterferon alfa-2b;
CISMeF synonym : Pharmacia brand of peginterferon alfa-2b; Schering brand of peginterferon alfa-2b; Schering-Plough brand of peginterferon alfa-2b; essex brand of peginterferon alfa-2b; merck brand of peginterferon alfa-2b; pegintron;
MeSH synonym : PEG INF alpha-2b; PEG INF alfa-2b; polyethylene glycol-interferon alfa-2b; PEG-IFNalpha-2b; pegylated interferon alfa-2b;
MeSH hyponym : peg-proline-INFalpha-2b; ViraferonPeg; PEG-Intron;
Is substance : O;
UNII : G8RGG88B68;
Origin ID : C417083;
UMLS CUI : C0796545;
ATC code(s)
- CISMeF manual mappings
- MeSH indexing information
- MeSH term(s) associated for indexing
- Pharmacological action(s)
- Record concept(s)
- See also inter- (CISMeF)
- Semantic type(s)
- UMLS correspondences (same concept)
- Validated automatic mappings to BTNT
https://www.has-sante.fr/jcms/p_3225401/fr/besremi
2020
false
false
false
France
treatment outcome
insurance, health, reimbursement
Ropeginterferon Alfa-2B
Ropeginterferon Alfa-2B
ropeginterferon alfa-2b
peginterferon alfa-2b
injections, subcutaneous
adult
polycythemia vera
evaluation of the transparency committee
interferon-alpha
recombinant proteins
Interferon alpha-2
polyethylene glycols
---
https://www.ema.europa.eu/en/medicines/human/EPAR/besremi
2019
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
Ropeginterferon Alfa-2B
Ropeginterferon Alfa-2B
peginterferon alfa-2b
drug approval
europe
polycythemia vera
adult
ropeginterferon alfa-2b
orphan drug production
injections, subcutaneous
receptor, interferon alpha-beta
product surveillance, postmarketing
aged
drug interactions
pregnancy
breast feeding
interferon-alpha
recombinant proteins
Interferon alpha-2
polyethylene glycols
---
http://www.cochrane.org/fr/CD005642/peg-interferon-alpha-2a-versus-peg-interferon-alpha-2b-pour-lhepatite-c-chronique
2014
false
false
false
France
United Kingdom
meta-analysis
french abstract
peginterferon alfa-2a
peginterferon alfa-2b
interferon-alpha
interferon-beta
antiviral agents
hepatitis C, chronic
treatment outcome
peginterferon alfa-2a
peginterferon alfa-2b
interferon-alpha
interferon-beta
antiviral agents
hepatitis C, chronic
polyethylene glycols
recombinant proteins
polyethylene glycols
recombinant proteins
---
https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/victrelis-2846.html
2014
false
Canada
French
English
drug evaluation
evaluation of the transparency committee
boceprevir
polyethylene glycols
proline
interferon-alpha
recombinant proteins
N-(3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl)-3-(2-((((1,1-dimethylethyl)amino)carbonyl)amino)-3,3-dimethyl-1-oxobutyl)-6,6-dimethyl-3-azabicyclo(3.1.0)hexan-2-carboxamide
drug therapy, combination
administration, oral
treatment outcome
hepatitis C, chronic
protease inhibitors
ribavirin
antiviral agents
peginterferon alfa-2b
costs and cost analysis
injections, subcutaneous
adult
clinical trials as topic
---
https://www.ema.europa.eu/medicines/human/EPAR/PegIntron
2012
United Kingdom
French
English
syndication feed
Contraindications, Procedure
antiviral agents
hepatitis C, chronic
antiviral agents
antiviral agents
antiviral agents
adult
injections, subcutaneous
drug therapy, combination
treatment outcome
antiviral agents
peginterferon alfa-2b
peginterferon alfa-2b
antiviral agents
hiv infections
combined modality therapy
aged
drug interactions
ribavirin
pregnancy
breast feeding
drug evaluation, preclinical
drug compounding
drug labeling
drug approval
coinfection
polyethylene glycols
summary of product characteristics
drug evaluation
package leaflet
Contraindications, Drug
---
http://www.has-sante.fr/portail/jcms/c_1298582/viraferonpeg
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-09/viraferonpeg_05092012_avis_ct12335.pdf
http://www.has-sante.fr/portail/jcms/c_701486/viraferonpeg
2012
France
French
peginterferon alfa-2b
polyethylene glycols
antiviral agents
peginterferon alfa-2b
insurance, health, reimbursement
adult
hepatitis C, chronic
drug therapy, combination
injections, subcutaneous
polyethylene glycols
adolescent
child
evaluation of the transparency committee
---
https://www.ema.europa.eu/medicines/human/EPAR/ViraferonPeg
2012
United Kingdom
French
English
syndication feed
Contraindications, Procedure
peginterferon alfa-2b
peginterferon alfa-2b
antiviral agents
treatment outcome
drug evaluation
adult
hepatitis C, chronic
antiviral agents
antiviral agents
antiviral agents
drug therapy, combination
injections, subcutaneous
polyethylene glycols
drug evaluation
summary of product characteristics
package leaflet
Contraindications, Drug
---
http://www.has-sante.fr/portail/jcms/c_977225/viraferonpeg
http://www.has-sante.fr/portail/upload/docs/application/pdf/2010-08/viraferonpeg_-_ct-8059.pdf
2010
France
French
antiviral agents
polyethylene glycols
injections, subcutaneous
child
adolescent
hepatitis C, chronic
peginterferon alfa-2b
treatment outcome
insurance, health, reimbursement
peginterferon alfa-2b
antiviral agents
polyethylene glycols
peginterferon alfa-2b
polyethylene glycols
evaluation of the transparency committee
---
http://www.has-sante.fr/portail/jcms/c_841617/viraferon-peg-peginterferon-alfa-interferon
http://www.has-sante.fr/portail/upload/docs/application/pdf/2009-01/viraferon_peg_-_ct-5474.pdf
2008
France
French
peginterferon alfa-2b
hepatitis C, chronic
antiviral agents
peginterferon alfa-2b
polyethylene glycols
polyethylene glycols
evaluation of the transparency committee
guidelines for drug use
---
